Results 271 to 280 of about 5,416,068 (411)

Contributions from the Chemical Laboratory of Harvard College

, 1881
Josiah P. Cooke
openalex   +2 more sources

A Laboratory Handbook of Bio-Chemistry [PDF]

, 1923
A. H.
openalex   +1 more source

Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis

Clinical Microbiology Reviews, 2015
R. Humphries, A. Linscott
semanticscholar   +1 more source

Exploration and future prospects of intelligent supervision technology and system development in biological laboratories. [PDF]

Sci Rep
Gao Y, Gu H, Ma Y.
europepmc   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Language Laboratories in University Teaching in Sweden [PDF]

, 1969
Editors, IALLT
core   +2 more sources

Studies from the psychological laboratory of the University of California. [PDF]

, 1902
George Malcolm Stratton
openalex   +1 more source

High Agreement Across Laboratories Between Different Alpha-Synuclein Seed Amplification Protocols. [PDF]

Eur J Neurol
Bräuer S, Weber M, Deuschle C, Julia K, Concha-Marambio L, Bernhardt AM, Kadam V, Mengel D, Ruf WP, Kassubek J, Schniewind I, Kuhs S, Rossi M, Parchi P, Levin J, Danzer KM, Synofzik M, Brockmann K, Falkenburger BH.   +18 more
europepmc   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

XII. Investigation of the arc in metallic vapours in an exhausted space. (Contribution from the Research Laboratory of General Electric Co., Schenectady, N.Y. [PDF]

, 1904
E. Weintraub
openalex   +1 more source